Affiliation:
1. The First Affiliated Hospital of Anhui Medical University
2. Soochow University
3. The First Affiliated Hospital of Anhui Medical University North District
4. Henan Provincial People’s Hospital
5. Affiliated Hospital of Jiangnan University
6. The First Affiliated Hospital of Bengbu Medical College
Abstract
Abstract
Background: Frailty is emerging as an important determinant of human health. The Geriatric 8 (G8) questionnaire, originally produced in English, is a common frailty screening tool designed specifically for older cancer patients. However, this tool has not yet been applied in China, partly due to a lack of a Chinese version. Therefore, this study aimed to translate the original G8 questionnaire into Chinese and validate its psychometric properties in Chinese older inpatients with cancer. Methods: The Chinese version of the G8 (C-G8) questionnaire was generated using Brislin’s model of translation. The psychometric properties of the C-G8, including content validity, known-group divergent validity, convergent validity, internal consistency, test-retest reliability, and inter-rater reliability, were all examined. Results: A total of 296 eligible subjects were consecutively enrolled in this cross-sectional study. The content validity index of the C-G8 were 0.8~1 at the item level and 0.975 at the scale level, respectively. The C-G8 identified more frail individuals among these older participants (>75 years) compared to their younger counterparts (65~75 years) (frailty prevalence: 87.1% vs. 70.9%, P=0.010). In addition, the convergent validity of the C-G8 was tested by correlating it with the FRAIL scale (r=-0.592, P<0.001), indicating a moderate correlation between these two instruments in screening frailty. Nevertheless, the C-G8 had a lower internal consistency (Cronbach’s α coefficient=0.501) but higher test-retest reliability and inter-rater reliability (intraclass correlation coefficient=0.913 and 0.993, respectively, P<0.001). Conclusion: The C-G8 questionnaire was demonstrated to have acceptable validity and reliability and hence could be applied to Chinese older cancer patients.
Publisher
Research Square Platform LLC